Ironwood Pharmaceuticals, Inc.
IRWD
$0.57
-$0.0244-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,757.18% | -38.12% | 523.95% | 79.34% | -282.89% |
| Total Depreciation and Amortization | -1.24% | -46.53% | 755.66% | -79.34% | 0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.28% | 188.66% | -30.01% | 47.79% | -65.66% |
| Change in Net Operating Assets | 248.98% | -216.11% | -193.21% | -65.64% | 488.52% |
| Cash from Operations | 31.16% | 53.91% | -70.46% | -25.61% | 25.54% |
| Capital Expenditure | -- | 100.00% | 72.41% | 14.71% | 67.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 72.41% | 14.71% | 98.38% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | 40.00% | 87.50% | -700.00% | 0.00% |
| Issuance of Common Stock | -97.04% | -- | -100.00% | -92.56% | 908.12% |
| Repurchase of Common Stock | -- | -- | 100.00% | 80.36% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 95.83% | -- | -- | -- |
| Cash from Financing | 100.04% | 45.18% | 45.00% | -217.40% | 69.44% |
| Foreign Exchange rate Adjustments | -133.33% | 180.77% | 49.02% | -312.50% | 148.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,624.71% | 102.01% | -8.10% | -154.50% | 252.20% |